High prevalence of SARS-CoV-2 antibodies in pregnant women after the second wave of infections in the inner-city of Johannesburg, Gauteng Province, South Africa.

Authors:
Sawry S; Le Roux J; Wolter N; Mbatha P; Bhiman J and 14 more

Journal:
Int J Infect Dis

Publication Year: 2022

DOI:
10.1016/j.ijid.2022.10.036

PMCID:
PMC9637015

PMID:
36347458

Journal Information

Full Title: Int J Infect Dis

Abbreviation: Int J Infect Dis

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Communicable Diseases

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declaration of competing interest CC has received grant support from Sanofi Pasteur and Advanced Vaccine Initiative and payment of travel costs from Parexel. NW and AvG have received grant support from Sanofi Pasteur and the Bill and Melinda Gates Foundation."

Evidence found in paper:

"Funding This study received funding from the South African Medical Research Council and the Wellcome Trust and the United Kingdom Foreign, Commonwealth and Development Office (Grant no 221003/Z/20/Z). This research was supported through the supply of Wantai ELISA kits by the World Health Organization Unity Studies, a global seroepidemiological standardization initiative, with funding to the World Health Organization by the COVID-19 Solidarity Response Fund and the German Federal Ministry of Health COVID-19 Research and development Fund. None of the funders had any role in the collection, analysis, and interpretation of data; in the writing of the report; and in the decision to submit the article for publication."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025